Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for Antipsychotic-Induced Extrapyramidal Symptoms
NCT03430596Phase 1Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- May 2018
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of pramipexole (3 arms), sponsored by Shanghai Mental Health Center. Primary endpoints: Simpson-Angus Scale at 8 weeks, Barnes Akathisia Rating Scale at 8 weeks and 1 more. Started May 2018; status: completed.
02
Drugs
pramipexole
Beyond the preview
Go deeper on NCT03430596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03430596.